Literature DB >> 26164757

Deletion of 11q12.3-11q13.1 in a patient with intellectual disability and childhood facial features resembling Cornelia de Lange syndrome.

Martine Isabel Boyle1, Cathrine Jespersgaard1, Lusine Nazaryan1, Kirstine Ravn1, Karen Brøndum-Nielsen1, Anne-Marie Bisgaard1, Zeynep Tümer2.   

Abstract

Deletions within 11q12.3-11q13.1 are very rare and to date only two cases have been described in the literature. In this study we describe a 23-year-old male patient with intellectual disability, behavioral problems, dysmorphic features, dysphagia, gastroesophageal reflux and skeletal abnormalities. Cornelia de Lange syndrome (CdLS, OMIM #122470; #300590; #610759; #300882; #614701) was suggested as a differential diagnosis in childhood although he lacked some of the features typical for this disorder. He does not have a mutation in any of the five known CdLS genes (NIPBL, SMC1A, SMC3, HDAC8, RAD21), but a 1.6Mb deletion at chromosome region 11q12.3-11q13.1 was detected by chromosome microarray. The deletion contains several genes including PPP2R5B, which has been associated with intellectual disability and overgrowth; NRXN2, which has been associated with intellectual disability and autism spectrum disorder; and CDCA5, which is part of the cohesin pathway, as are all the five known CdLS genes. It is therefore possible that deletion of CDCA5 may account for some of the CdLS like features of the present case.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  11q12.3–11q13.1; CDCA5; Cornelia de Lange syndrome; Intellectual disability; NRXN2; PPP2R5B

Mesh:

Substances:

Year:  2015        PMID: 26164757     DOI: 10.1016/j.gene.2015.07.016

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Loss of neurexin-1 in Drosophila melanogaster results in altered energy metabolism and increased seizure susceptibility.

Authors:  Kyra A Levy; Eliana D Weisz; Thomas A Jongens
Journal:  Hum Mol Genet       Date:  2022-10-10       Impact factor: 5.121

2.  A rare exonic NRXN3 deletion segregating with neurodevelopmental and neuropsychiatric conditions in a three-generation Chinese family.

Authors:  Haiming Yuan; Qingming Wang; Yanhui Liu; Wei Yang; Yi He; James F Gusella; Jiage Song; Yiping Shen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-08-04       Impact factor: 3.568

3.  CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker.

Authors:  Hao Hu; Yuan Xiang; Xiao-Yu Zhang; Yang Deng; Fu-Jian Wan; You Huang; Xing-Hua Liao; Tong-Cun Zhang
Journal:  Oncol Rep       Date:  2022-08-25       Impact factor: 4.136

Review 4.  Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions.

Authors:  Bryan Mowry; Jean Giacomotto; Alisha Tromp
Journal:  Mol Psychiatry       Date:  2020-11-15       Impact factor: 15.992

Review 5.  Protein phosphatase 2A - structure, function and role in neurodevelopmental disorders.

Authors:  Priyanka Sandal; Chian Ju Jong; Ronald A Merrill; Jianing Song; Stefan Strack
Journal:  J Cell Sci       Date:  2021-07-06       Impact factor: 5.235

6.  The within-subject application of diffusion tensor MRI and CLARITY reveals brain structural changes in Nrxn2 deletion mice.

Authors:  Eleftheria Pervolaraki; Adam L Tyson; Laura C Andreae; James Dachtler; Francesca Pibiri; Steven L Poulter; Amy C Reichelt; R John Rodgers; Steven J Clapcote; Colin Lever
Journal:  Mol Autism       Date:  2019-02-28       Impact factor: 7.509

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.